Related Experiment Video
Updated: Mar 7, 2026

08:04
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
2.6K
Endocrine system on chip for a diabetes treatment model
Dao Thi Thuy Nguyen1, Danny van Noort2, In-Kyung Jeong3
1Department of Chemistry and Nano Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
Biofabrication
|February 22, 2017
Summary
Researchers developed an
Area of Science:
- Endocrinology
- Biotechnology
- Cell Biology
Background:
- The endocrine system regulates vital bodily functions through hormones.
- Diabetes mellitus is a major endocrine disorder linked to insulin deficiency or resistance.
- Current drug screening methods for diabetes can be improved with more physiologically relevant models.
Purpose of the Study:
- To create a novel 'endocrine system on chip' model for diabetes research.
- To co-culture pancreatic beta-cells and intestinal L-cells to mimic endocrine interactions.
- To assess glucose-stimulated insulin and glucagon-like peptide-1 (GLP-1) secretion dynamics.
Main Methods:
- Utilized a microfluidic perfused 3D cell-culture chip.
- Co-cultured pancreatic beta-cell line (INS-1) and intestinal L-cell line (GLUTag).
- Measured dynamic release of GLP-1 and insulin at varying glucose concentrations (0.5 mM and 20 mM).
Main Results:
- The 3D co-culture model demonstrated high cell viability (>95%) and aggregate formation.
- Both cell lines showed increased GLP-1 and insulin production in response to glucose stimuli compared to 2D culture.
- The co-culture system exhibited enhanced insulin production and faster saturation at high glucose levels.
Conclusions:
- The developed 'endocrine system on chip' accurately models dynamic hormonal changes in a glucose-dependent manner.
- This platform is a promising tool for screening diabetes therapeutics, including GLP-1 analogues and insulin secretagogues.
- The 3D co-culture approach offers a more physiologically relevant system for endocrine disease research.

